CINTHIA ROJAS: Open Payments
NPI 1417447756 · WALNUT CREEK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,975 in 83 payments from 11 companies in 2025. Trend: 2023 $428 · 2024 $1,933 · 2025 $1,975
Food & beverage: $1,975
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $495 |
| Janssen Biotech, Inc. | 19 | $425 |
| Lilly USA, LLC | 13 | $256 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $211 |
| Aimmune Therapeutics, Inc. | 9 | $171 |
| Madrigal Pharmaceuticals | 7 | $165 |
| Ardelyx, Inc. | 6 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| PFIZER INC. | 1 | $24 |
| Exact Sciences Corporation | 1 | $21 |
Products named: TREMFYA, SKYRIZI, OMVOH, XIFAXAN, REZDIFFRA, ZENPEP, RINVOQ, IBSRELA.
Industry payments across CA — which companies pay providers there.
